Evaxion A/S
EVAXNasdaqHealthcare · Biological Products, (No Diagnostic Substances) · G7 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)May 15, 2025
- Merck & Co., Inc.Passive (13G)Feb 3, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 32,128 | 1.0 | -10.2% |
| Apr 30, 2026 | 35,763 | 1.0 | +16.9% |
| Apr 15, 2026 | 30,580 | 1.4 | -18.8% |
| Mar 31, 2026 | 37,653 | 1.4 | -35.3% |
| Mar 13, 2026 | 58,172 | 1.4 | +10.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KFORM 6-KMay 12, 2026
- 6-KFORM 6-KMay 7, 2026
- 6-KFORM 6-KMay 4, 2026
- 6-KFORM 6-KApr 27, 2026
- 3OWNERSHIP DOCUMENTApr 24, 2026
- 6-KFORM 6-KApr 22, 2026
- 6-KFORM 6-KApr 17, 2026
- 6-KFORM 6-KApr 17, 2026
- 6-KFORM 6-KApr 16, 2026
- 3/AOWNERSHIP DOCUMENTApr 10, 2026
- 6-KFORM 6-KApr 7, 2026
- 3/AOWNERSHIP DOCUMENTApr 2, 2026
- 3/AOWNERSHIP DOCUMENTApr 1, 2026
- 3/AOWNERSHIP DOCUMENTMar 31, 2026
- 6-KFORM 6-KMar 30, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.